Family Office Of America (FOFA) Cash & Current Investments (2021 - 2026)
Family Office Of America (FOFA) reported Cash & Current Investments of $343220.0 for Q1 2026, down 39.28% on a YoY basis from $565222.0 in Q1 2025, and up 120.3% sequentially from $155798.0 in Q4 2025.
Family Office Of America (FOFA) Cash & Current Investments (2021 - 2026) Analysis & Trends
Family Office Of America (FOFA) has 6 years of Cash & Current Investments data on file, last reported at $343220.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments fell 39.28% year-over-year to $343220.0; the trailing twelve-month figure through Mar 2026 stood at $343220.0 (down 39.28% YoY), and the FY2025 full-year result was $155798.0, up 1046.75% from the prior year.
- Cash & Current Investments grew to $343220.0 in Q1 2026, from $155798.0 in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $827598.0 in Q3 2025 to a low of $2431.0 in Q4 2023.
- A 5-year average of $230941.4 and a median of $123858.0 in 2022 frame the typical range for Cash & Current Investments.
- Across the five-year window, Cash & Current Investments slumped 98.04% in 2023 and soared 1672.01% in 2025, its largest moves.
- Tracing FOFA's Cash & Current Investments over 5 years: stood at $123858.0 in 2022, then tumbled by 98.04% to $2431.0 in 2023, then jumped by 458.86% to $13586.0 in 2024, then jumped by 1046.75% to $155798.0 in 2025, then surged by 120.3% to $343220.0 in 2026.
- Business Quant data shows FOFA's Cash & Current Investments at $343220.0 in Q1 2026, $155798.0 in Q4 2025, and $827598.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.12 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 577.00 Mn |
| 10 | Family Office Of America | 27.22 Mn | 26.88 Mn | 783,126.00 | 343,220.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 343,220.00 |
| Dec 31, 2025 | 155,798.00 |
| Sep 30, 2025 | 827,598.00 |
| Jun 30, 2025 | 585,273.00 |
| Mar 31, 2025 | 565,222.00 |
| Dec 31, 2024 | 13,586.00 |
| Sep 30, 2024 | 46,704.00 |
| Jun 30, 2024 | 62,956.00 |
| Mar 31, 2024 | 90,571.00 |
| Dec 31, 2023 | 2,431.00 |
| Sep 30, 2023 | 55,331.00 |
| Jun 30, 2023 | 78,627.00 |
| Mar 31, 2023 | 70,105.00 |
| Dec 31, 2022 | 123,858.00 |
| Sep 30, 2022 | 225,952.00 |
| Jun 30, 2022 | 280,287.00 |
| Mar 31, 2022 | 398,485.00 |
| Dec 31, 2021 | 582,284.00 |
| Sep 30, 2021 | 703,921.00 |
| Jun 30, 2021 | 1.06 Mn |